Oncology Drugs Market Size, Share & Industry Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI103431

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 12.12% from 2026-2034
Unit	Value (USD Billion)
Segmentation	By Drug Class Cytotoxic Drugs Alkylating Agents Antimetabolites Others Targeted Drugs Monoclonal Antibodies Others Hormonal Drugs Others
	By Therapy Chemotherapy Targeted Therapy Immunotherapy
	By Indication Lung Cancer Stomach Cancer Colorectal Cancer Breast Cancer Prostate Cancer Others
	By Dosage Form Solid Tablets Capsules Liquid Injectable Prefilled Syringes Others
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
	By Region North America (By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region) U.S. (By Drug Class) Canada (By Drug Class) Europe (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region) U.K. (By Drug Class) Germany (By Drug Class) France (By Drug Class) Italy (By Drug Class) Spain (By Drug Class) Scandinavia (By Drug Class) Rest of Europe (By Drug Class) Asia Pacific (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region) Japan (By Drug Class) China (By Drug Class) India (By Drug Class) Australia (By Drug Class) Southeast Asia (By Drug Class) Rest of Asia Pacific (By Drug Class) Latin America (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region) Brazil (By Drug Class) Mexico (By Drug Class) Rest of Latin America (By Drug Class) Middle East & Africa (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region) South Africa (By Drug Class) GCC (By Drug Class) Rest of Middle East & Africa (By Drug Class)